Inventor · disambiguated record
Victor H. Obungu
Also filed as: OBUNGU VICTOR H
10 granted patents·4 pending applications·4 citations·filing 2009–2024
79Inventor score
Files withLILLY CO ELI14
Top patents by PatentIndex Score
14 records- 0185US11396545B2BTLA agonist antibodies and uses thereofLILLY CO ELI·Filed 2020·Granted Jul 26, 2022·2 cites·14 claims
- 0278US7892546B2Anti-CXCR4 antibodiesLILLY CO ELI·Filed 2009·Granted Feb 22, 2011·2 cites·10 claims
- 0371US2024141033A1Compounds and methods targeting interleukin-34LILLY CO ELI·Filed 2023·Application pending·0 cites
- 0471US2023279098A1Compounds and methods targeting interleukin-34LILLY CO ELI·Filed 2023·Application pending·0 cites
- 0567US11649280B2Antibodies to IL-34LILLY CO ELI·Filed 2021·Granted May 16, 2023·0 cites·7 claims
- 0663US11976114B2Compounds and methods targeting interleukin-34LILLY CO ELI·Filed 2022·Granted May 7, 2024·0 cites·5 claims
- 0762US2024309082A1Compounds and methods targeting interleukin-34LILLY CO ELI·Filed 2024·Application pending·0 cites
- 0857US11104711B2Growth differentiation factor 15 agonist compounds and methods of using the sameLILLY CO ELI·Filed 2019·Granted Aug 31, 2021·0 cites·10 claims
- 0957US10604573B2BTLA agonist antibodies and uses thereofLILLY CO ELI·Filed 2018·Granted Mar 31, 2020·0 cites·9 claims
- 1057US8003102B2Anti-CXCR4 antibodiesLILLY CO ELI·Filed 2010·Granted Aug 23, 2011·0 cites·2 claims
- 1150US10913799B2Anti-RANKL antibodies and uses thereofLILLY CO ELI·Filed 2017·Granted Feb 9, 2021·0 cites·10 claims
- 1248US2025296997A1Compounds and methods targeting interleukin-34LILLY CO ELI·Filed 2022·Application pending·0 cites
- 1337US10584174B2Anti-Dkk-1-anti-RANKL bispecific antibody compoundsLILLY CO ELI·Filed 2016·Granted Mar 10, 2020·0 cites·12 claims
- 1431US11492386B2Parathyroid hormone-anti-RANKL antibody fusion compoundsLILLY CO ELI·Filed 2017·Granted Nov 8, 2022·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Victor H. Obungu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →